Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,832.00 -2,505.66 (-3.96%) CMC Crypto 200
1,256.40 -101.60 (-7.48%)
BlackRock Floating Rate Income Strategies Fund, Inc. (FRA)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 13.21 |
| Open | 13.21 |
| Bid | 12.95 x 1000 |
| Ask | 13.24 x 900 |
| Day's range | 13.22 - 13.25 |
| 52-week range | 11.43 - 13.29 |
| Volume | |
| Avg. volume | 151,033 |
| Market cap | 466.474M |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 7.48 |
| EPS (TTM) | 1.77 |
| Earnings date | N/A |
| Forward dividend & yield | 1.49 (11.25%) |
| Ex-dividend date | 14 May 2024 |
| 1y target est | N/A |
CNW GroupBioVaxys and The Ohio State University Extend Research Collaboration
BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (5LB: FRA) ("BioVaxys" or "the Company"), is pleased to announce that it has further extended its research collaboration with The Ohio State University ("The Ohio State") for SARS-CoV-2, SARS-CoV-1, and pan-sarbecovirus vaccine research. This is the second twelve-month extension of the research collaboration between BioVaxys and the University since 2021.
© 2024 Yahoo. All rights reserved.